Publications

Title

Author

Year

Individual-level factors associated with variation in mycobacterial-specific immune response: Gender and previous BCG vaccination status.

RHODES, SJ; KNIGHT, GM; FIELDING, K; Scriba, TJ; Pathan, AA; McShane, H; FLETCHER, H; WHITE, RG;

2015

Tuberculosis (Edinburgh, Scotland), (2015).96, 10.1016/j.tube.2015.10.002.

Microscopic Observation Drug Susceptibility Assay for Rapid Diagnosis of Lymph Node Tuberculosis and Detection of Drug Resistance.

Kirwan, DE; Ugarte-Gil, C; Gilman, RH; Caviedes, L; Rizvi, H; Ticona, E; Chavez, G; Cabrera, JL; Matos, ED; Evans, CA; MOORE, DA J; Friedland, JS; Lymph Node TB Working Group, Peru,;

2015

Journal of clinical microbiology, (2015).54 1 10.1128/JCM.02227-15.

Effect of isoniazid preventive therapy on immune responses to mycobacterium tuberculosis: an open label randomised, controlled, exploratory study.

Biraro, IA; EGESA, M; Kimuda, S; SMITH, SG; TOULZA, F; Levin, J; Joloba, M; Katamba, A; COSE, S; DOCKRELL, HM; ELLIOTT, AM;

2015

BMC infectious diseases, (2015).15 1 10.1186/s12879-015-1201-8.

A Tuberculin Skin Test Survey and the Annual Risk of Mycobacterium tuberculosis Infection in Gambian School Children.

ADETIFA, IM O; Muhammad, AK; JEFFRIES, D; Donkor, S; Borgdorff, MW; Corrah, T; D'ALESSANDRO, U;

2015

PloS one, (2015).10 10 10.1371/journal.pone.0139354.

Tuberculosis screening using ability to provide sputum in an endemic emergency department.

Ticona, E; Huaman, MA; Huaroto, LM; Burgos, M; Brett, M; Escombe, R; MOORE, DA J;

2015

The European respiratory journal, (2015).47 1 10.1183/13993003.00877-2015.

Implementing the End TB Strategy and the intersection with the Sustainable Development Goals, 2016-2030.

FITCHETT, JR; MacPherson, P; CORBETT, EL;

2015

Transactions of the Royal Society of Tropical Medicine and Hygiene, (2015).110 3 10.1093/trstmh/trw010.

Tuberculosis.

Bloom, B.R. White, RG;

2015

Disease Control Priorities in Developing Countries , World Bank Group (2015).

The Distribution of Fitness Costs of Resistance-Conferring Mutations Is a Key Determinant for the Future Burden of Drug-Resistant Tuberculosis: A Model-Based Analysis.

KNIGHT, GM; Colijn, C; Shrestha, S; Fofana, M; Cobelens, F; WHITE, RG; Dowdy, DW; Cohen, T;

2015

Clinical infectious diseases, (2015).61Supp Suppl 10.1093/cid/civ579.

Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines.

Schito, M; Migliori, GB; FLETCHER, HA; McNerney, R; Centis, R; D'Ambrosio, L; Bates, M; Kibiki, G; Kapata, N; Corrah, T; Bomanji, J; Vilaplana, C; Johnson, D; Mwaba, P; Maeurer, M; Zumla, A;

2015

Clinical infectious diseases, (2015).61Supp Suppl 10.1093/cid/civ609.

Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.

Getahun, H; Matteelli, A; Abubakar, I; Aziz, MA; Baddeley, A; Barreira, D; Den Boon, S; Borroto Gutierrez, SM; Bruchfeld, J; Burhan, E; Cavalcante, S; Cedillos, R; Chaisson, R; Chee, CB-E; Chesire, L; CORBETT, E; Dara, M; Denholm, J; De Vries, G; Falzon, D; Ford, N; Gale-Rowe, M; Gilpin, C; Girardi, E; Go, U-Y; ... Raviglione, M.

2015

The European respiratory journal, (2015).46 6 10.1183/13993003.01245-2015.